Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Fuso Pharmaceutical Industries,Ltd. ( (JP:4538) ) has provided an update.
Fuso Pharmaceutical Industries, Ltd. announced that there will be no revisions to its financial results forecast for the fiscal year ending March 31, 2026, despite a recent patent infringement lawsuit. The company also confirmed that there will be no changes to its dividend forecast, signaling stability in its financial outlook and commitment to shareholder returns.
More about Fuso Pharmaceutical Industries,Ltd.
Fuso Pharmaceutical Industries, Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of pharmaceutical products. The company is listed on the Tokyo Stock Exchange Prime Market and is known for its commitment to innovation and quality in healthcare solutions.
Average Trading Volume: 26,160
Technical Sentiment Signal: Sell
Current Market Cap: Yen18.93B
Find detailed analytics on 4538 stock on TipRanks’ Stock Analysis page.